CorMedix Inc. (CRMD) Financial Statements (2024 and earlier)

Company Profile

Business Address 300 CONNELL DRIVE
BERKELEY HEIGHTS, NJ 07922
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments52,40155,60158,79259,00064,62261,687
Cash and cash equivalents19,70025,26843,14843,25448,93045,389
Short-term investments32,70130,33215,64415,74615,69316,298
Restricted cash and investments87126124114121129
Inventory, net of allowances, customer advances and progress billings    023
Inventory    023
Prepaid expense1,255311192840
Other undisclosed current assets8821,051624531585644
Total current assets:54,62556,78159,55159,66465,35962,503
Noncurrent Assets
Operating lease, right-of-use asset709743775807838869
Property, plant and equipment1,5971,6081,6101,5031,4481,459
Restricted cash and investments102102102102102102
Total noncurrent assets:2,4082,4522,4872,4132,3892,430
TOTAL ASSETS:57,03359,23462,03862,07767,74864,934
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7,2454,5366,1767,2506,9325,925
Employee-related liabilities2,3191,7871,756
Accounts payable2,9011,4472,2021,7672,4961,740
Accrued liabilities4,3443,0893,9743,1632,6492,430
Other undisclosed current liabilities143139135(2,188)(1,660)(1,631)
Total current liabilities:7,3874,6756,3115,0625,2724,294
Noncurrent Liabilities
Long-term debt and lease obligation:    703737770
Liabilities, other than long-term debt594631668   
Operating lease, liability594631668703737770
Other undisclosed noncurrent liabilities    (703)(737)(770)
Total noncurrent liabilities:594631668703737770
Total liabilities:7,9825,3066,9795,7656,0095,064
Equity
Equity, attributable to parent49,05153,92855,06056,31261,73959,869
Preferred stock000000
Common stock464543414139
Additional paid in capital346,116339,710330,295323,377321,956312,474
Accumulated other comprehensive income9110183464050
Accumulated deficit(297,202)(285,928)(275,361)(267,152)(260,298)(252,693)
Total equity:49,05153,92855,06056,31261,73959,869
TOTAL LIABILITIES AND EQUITY:57,03359,23462,03862,07767,74864,934

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues   307218
Operating lease, lease income     5050
Cost of revenue   (0)(1)(0)(2)
Gross profit:   295216
Operating expenses(11,805)(11,017)(8,419)(6,967)(8,261)(7,038)
Operating loss:(11,805)(11,017)(8,389)(6,962)(8,240)(7,032)
Nonoperating income531450180108502
Investment income, nonoperating      14
Loss, foreign currency transaction, before tax      (10)
Other nonoperating income (expense)53145018010850(2)
Interest and debt expense(6)(9)(9)(9)(4)(5)
Loss from continuing operations before equity method investments, income taxes:(11,279)(10,576)(8,218)(6,862)(8,194)(7,036)
Other undisclosed income from continuing operations before income taxes   994 
Loss from continuing operations before income taxes:(11,279)(10,576)(8,209)(6,854)(8,190)(7,036)
Income tax benefit     586 
Loss from continuing operations:(11,279)(10,576)(8,209)(6,854)(7,605)(7,036)
Loss before gain (loss) on sale of properties:(6,854)(7,605)(7,036)
Other undisclosed net income      2
Net loss:(11,279)(10,576)(8,209)(6,854)(7,605)(7,034)
Other undisclosed net income attributable to parent69    
Net loss attributable to parent:(11,274)(10,567)(8,209)(6,854)(7,605)(7,034)
Other undisclosed net income available to common stockholders, basic     15,20514,034
Net income (loss) available to common stockholders, diluted:(11,274)(10,567)(8,209)(6,854)7,6007,000

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(11,279)(10,576)(8,209)(6,854)(7,605)(7,034)
Other comprehensive income (loss)(11)18376(10)(37)
Comprehensive loss:(11,290)(10,558)(8,172)(6,847)(7,615)(7,071)
Other undisclosed comprehensive income, net of tax, attributable to parent69    
Comprehensive loss, net of tax, attributable to parent:(11,284)(10,549)(8,172)(6,847)(7,615)(7,071)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: